105 related articles for article (PubMed ID: 27179633)
1. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
2. TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.
Cyr AR; Kulak MV; Park JM; Bogachek MV; Spanheimer PM; Woodfield GW; White-Baer LS; O'Malley YQ; Sugg SL; Olivier AK; Zhang W; Domann FE; Weigel RJ
Oncogene; 2015 Jan; 34(4):436-44. PubMed ID: 24469049
[TBL] [Abstract][Full Text] [Related]
3. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.
Ferguson RD; Novosyadlyy R; Fierz Y; Alikhani N; Sun H; Yakar S; Leroith D
Breast Cancer Res; 2012 Jan; 14(1):R8. PubMed ID: 22226054
[TBL] [Abstract][Full Text] [Related]
4. Loss of CD24 expression promotes ductal branching in the murine mammary gland.
Cremers N; Deugnier MA; Sleeman J
Cell Mol Life Sci; 2010 Jul; 67(13):2311-22. PubMed ID: 20352469
[TBL] [Abstract][Full Text] [Related]
5. ZBTB28 inhibits breast cancer by activating IFNAR and dual blocking CD24 and CD47 to enhance macrophages phagocytosis.
Li L; Gong Y; Tang J; Yan C; Li L; Peng W; Cheng Z; Yu R; Xiang Q; Deng C; Mu J; Xia J; Luo X; Wu Y; Xiang T
Cell Mol Life Sci; 2022 Jan; 79(2):83. PubMed ID: 35048182
[TBL] [Abstract][Full Text] [Related]
6. Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.
Duex JE; Owens C; Chauca-Diaz A; Dancik GM; Vanderlinden LA; Ghosh D; Leivo MZ; Hansel DE; Theodorescu D
Cancer Res; 2017 Sep; 77(18):4858-4867. PubMed ID: 28674079
[TBL] [Abstract][Full Text] [Related]
7. High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice.
Watson KL; Stalker L; Jones RA; Moorehead RA
BMC Cancer; 2015 Feb; 15():37. PubMed ID: 25655427
[TBL] [Abstract][Full Text] [Related]
8. Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness.
Cismas S; Pasca S; Crudden C; Trocoli Drakensjo I; Suleymanova N; Zhang S; Gebhard B; Song D; Neo S; Shibano T; Smith TJ; Calin GA; Girnita A; Girnita L
Mol Cancer Res; 2023 Dec; 21(12):1288-1302. PubMed ID: 37584671
[TBL] [Abstract][Full Text] [Related]
9. Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after Parturition.
Katz TA; Liao SG; Palmieri VJ; Dearth RK; Pathiraja TN; Huo Z; Shaw P; Small S; Davidson NE; Peters DG; Tseng GC; Oesterreich S; Lee AV
Cancer Prev Res (Phila); 2015 Oct; 8(10):1000-9. PubMed ID: 26290394
[TBL] [Abstract][Full Text] [Related]
10. Oxalate induces breast cancer.
Castellaro AM; Tonda A; Cejas HH; Ferreyra H; Caputto BL; Pucci OA; Gil GA
BMC Cancer; 2015 Oct; 15():761. PubMed ID: 26493452
[TBL] [Abstract][Full Text] [Related]
11. Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer.
Mishra AK; Ye T; Banday S; Thakare RP; Su CT; Pham NNH; Ali A; Kulshreshtha A; Chowdhury SR; Simone TM; Hu K; Zhu LJ; Eisenhaber B; Deibler SK; Simin K; Thompson PR; Kelliher MA; Eisenhaber F; Malonia SK; Green MR
Cell Rep; 2024 Apr; 43(4):114041. PubMed ID: 38573857
[TBL] [Abstract][Full Text] [Related]
12. A Novel Mutation in Insulin-Like Growth Factor 1 Receptor (c.641-2A>G) Is Associated with Impaired Growth, Hypoglycemia, and Modified Immune Phenotypes.
Shapiro MR; Foster TP; Perry DJ; Rosenfeld RG; Dauber A; McNichols JA; Muir A; Hwa V; Brusko TM; Jacobsen LM
Horm Res Paediatr; 2020; 93(5):322-334. PubMed ID: 33113547
[TBL] [Abstract][Full Text] [Related]
13. Prospective identification of tumorigenic breast cancer cells.
Al-Hajj M; Wicha MS; Benito-Hernandez A; Morrison SJ; Clarke MF
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):3983-8. PubMed ID: 12629218
[TBL] [Abstract][Full Text] [Related]
14. Targeting CD24 as a novel immunotherapy for solid cancers.
Yang Y; Zhu G; Yang L; Yang Y
Cell Commun Signal; 2023 Nov; 21(1):312. PubMed ID: 37919766
[TBL] [Abstract][Full Text] [Related]
15. SIK2-positive tumor epithelial cells in breast cancer maybe potential anti-cancer messengers: A systematic analysis from a single-cell perspective.
Wu Q; Qu C; Xin L; Yang F; Xu L
Environ Toxicol; 2024 Feb; 39(2):768-782. PubMed ID: 37772720
[TBL] [Abstract][Full Text] [Related]
16. Single-cell morphology encodes metastatic potential.
Wu PH; Gilkes DM; Phillip JM; Narkar A; Cheng TW; Marchand J; Lee MH; Li R; Wirtz D
Sci Adv; 2020 Jan; 6(4):eaaw6938. PubMed ID: 32010778
[TBL] [Abstract][Full Text] [Related]
17. Primary and Immortalized Cultures of Human Proximal Tubule Cells Possess Both Progenitor and Non-Progenitor Cells That Can Impact Experimental Results.
Shrestha S; Haque ME; Ighofose E; Mcmahon M; Kalyan G; Guyer R; Kalonick M; Kochanowski J; Wegner K; Somji S; Sens DA; Garrett SH
J Pers Med; 2023 Mar; 13(4):. PubMed ID: 37108999
[TBL] [Abstract][Full Text] [Related]
18. CD24 in Head and Neck Malignancies-An Uprising Biomarker?
Carmel Neiderman NN; Shapira S; Klein L; Rafael D; Gorelik G; Kampel L; Arber N; Muhanna N
J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138858
[TBL] [Abstract][Full Text] [Related]
19. p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing pro-survival mitophagy.
Li W; Huang C; Qiu L; Tang Y; Zhang X; Zhang L; Zhao H; Miyagishi M; Kasim V; Wu S
Oncogene; 2024 May; ():. PubMed ID: 38773262
[TBL] [Abstract][Full Text] [Related]
20. PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer.
Shin GC; Lee HM; Kim N; Seo SU; Kim KP; Kim KH
Exp Mol Med; 2024 Feb; 56(1):192-209. PubMed ID: 38200153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
